| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0149-2918(02)85147-5 |
| P698 | PubMed publication ID | 12075941 |
| P2093 | author name string | David S Burgess | |
| Jennifer P Dugan | |||
| Robin R Feuge | |||
| P2860 | cites work | Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old) | Q34086738 |
| Chlamydia pneumoniae antibody titers are significantly associated with acute stroke and transient cerebral ischemia: the West Birmingham Stroke Project | Q34457169 | ||
| Chlamydia pneumoniae (TWAR). | Q35367697 | ||
| Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells | Q35488540 | ||
| Infection as a risk factor for infarction and atherosclerosis | Q36845622 | ||
| Use of HL cells for improved isolation and passage of Chlamydia pneumoniae | Q37182583 | ||
| Identification of a new group of Chlamydia psittaci strains called TWAR. | Q37213605 | ||
| Chlamydia pneumoniae exposure and inflammatory markers in acute coronary syndrome (CIMACS). | Q37873779 | ||
| Chlamydia pneumoniae and the risk of first ischemic stroke : The Northern Manhattan Stroke Study | Q37876105 | ||
| Description and status of the azithromycin and coronary events study (ACES). | Q37876308 | ||
| Rationale and design of a secondary prevention trial of antibiotic use in patients after myocardial infarction: the WIZARD (weekly intervention with zithromax [azithromycin] for atherosclerosis and its related disorders) trial | Q37876312 | ||
| Detection of Chlamydia pneumoniae in arterial tissues | Q37876382 | ||
| Chlamydia pneumoniae infection and incident coronary heart disease: the Atherosclerosis Risk in Communities Study | Q37878104 | ||
| Relation of Chlamydia pneumoniae serology to mortality and incidence of ischaemic heart disease over 13 years in the caerphilly prospective heart disease study | Q37878617 | ||
| Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamyd | Q37878769 | ||
| Prospective study of Chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarction | Q37878896 | ||
| Pathogenesis of atherosclerosis: a possible relation to infection | Q37879499 | ||
| Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction | Q37880581 | ||
| High prevalence of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in patients with cardiovascular disease and in middle-aged blood donors. | Q37880679 | ||
| Increased fibrinogen levels are associated with persistent Chlamydia pneumoniae infection in unstable coronary artery disease | Q37880979 | ||
| Interactive role of infection, inflammation and traditional risk factors in atherosclerosis and coronary artery disease | Q37881093 | ||
| Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease | Q37881317 | ||
| Role of infection as a risk factor for atherosclerosis, myocardial infarction, and stroke | Q37881326 | ||
| Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model | Q37881464 | ||
| Chlamydia pneumoniae antibody response in patients with acute myocardial infarction and their follow-up | Q37881662 | ||
| Chronic infection in the etiology of atherosclerosis--the case for Chlamydia pneumoniae | Q37882065 | ||
| Chronic infections and coronary heart disease: is there a link? | Q37882245 | ||
| Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS Pilot Study. ROXIS Study Group | Q37882250 | ||
| Chlamydia pneumoniae and acute myocardial infarction in Jerusalem | Q37882349 | ||
| A possible association of Chlamydia pneumoniae infection and acute myocardial infarction in patients younger than 65 years of age. | Q37882360 | ||
| Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction | Q37882420 | ||
| Lymphocyte responses to Chlamydia antigens in patients with coronary heart disease | Q37882557 | ||
| Detection of Chlamydia pneumoniae in atherosclerotic plaques in the walls of arteries of lower extremities from patients undergoing bypass operation for arterial obstruction | Q37882562 | ||
| Infection and coronary heart disease | Q37882569 | ||
| Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen | Q37882581 | ||
| Detection of Chlamydia pneumoniae in human nonrheumatic stenotic aortic valves | Q37883146 | ||
| Demonstration of Chlamydia pneumoniae in the walls of abdominal aortic aneurysms | Q37883353 | ||
| Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. The Chlamydia pneumoniae/Atherosclerosis Study Group | Q37883953 | ||
| Association of chlamydial infection with cerebrovascular disease | Q37884018 | ||
| Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease | Q37884972 | ||
| Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy | Q37885296 | ||
| Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery | Q37886058 | ||
| Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors | Q37886448 | ||
| Lp(a) lipoprotein, IgG, IgA and IgM antibodies to Chlamydia pneumoniae and HLA class II genotype in early coronary artery disease | Q37887196 | ||
| : Risk factors for seropositivity and association with coronary heart disease | Q37887420 | ||
| Growth in serum-free medium improves isolation of Chlamydia pneumoniae | Q37890113 | ||
| Past infection by Chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis. Atherosclerosis Risk in Communities (ARIC) Study Investigators | Q37890128 | ||
| Evaluation of serological methods in the diagnosis of Chlamydia pneumoniae pneumonia during an epidemic in Finland | Q37890204 | ||
| Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain | Q37890285 | ||
| Chlamydia pneumoniae-specific circulating immune complexes in patients with chronic coronary heart disease | Q37891247 | ||
| Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries | Q37891287 | ||
| Use of HEp-2 cells for improved isolation and passage of Chlamydia pneumoniae | Q37892713 | ||
| Association of Prior Infection With Chlamydia pneumoniae and Angiographically Demonstrated Coronary Artery Disease | Q37892814 | ||
| Chronic Chlamydia pneumoniae Infection as a Risk Factor for Coronary Heart Disease in the Helsinki Heart Study | Q37893723 | ||
| Chlamydia pneumoniae strain TWAR antibody and angiographically demonstrated coronary artery disease | Q37894988 | ||
| A sensitive cell line, HL cells, for isolation and propagation of Chlamydia pneumoniae strain TWAR. | Q37896100 | ||
| Circulating immune complexes containing chlamydial lipopolysaccharide in acute myocardial infarction | Q37896424 | ||
| A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. | Q37896793 | ||
| Culture-negative endocarditis probably due to Chlamydia pneumoniae | Q37897113 | ||
| Countrywide epidemics of Chlamydia pneumoniae, strain TWAR, in Scandinavia, 1981-1983. | Q37898201 | ||
| Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction | Q37899465 | ||
| A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections | Q37902805 | ||
| Prevalence in human beings of antibodies to Chlamydia IOL-207, an atypical strain of chlamydia | Q37903246 | ||
| An epidemic of mild pneumonia due to an unusual strain of Chlamydia psittaci | Q37904432 | ||
| Molecular bases of the acute coronary syndromes | Q40530238 | ||
| Influence of lipoproteins on endothelial function. | Q40695906 | ||
| Effect of 3 months of antimicrobial treatment with clarithromycin in acute non-q-wave coronary syndrome | Q43943292 | ||
| Viral coronary arteritis and myocardial infarction | Q67803890 | ||
| Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis | Q72209255 | ||
| P433 | issue | 5 | |
| P921 | main subject | atherosclerosis | Q12252367 |
| Chlamydia pneumoniae | Q62869737 | ||
| P304 | page(s) | 719-735 | |
| P577 | publication date | 2002-05-01 | |
| P1433 | published in | Clinical Therapeutics | Q15716601 |
| P1476 | title | Review of evidence for a connection between Chlamydia pneumoniae and atherosclerotic disease | |
| P478 | volume | 24 |
| Q37863427 | Antibiotics active against Chlamydia do not reduce the risk of myocardial infarction |
| Q37207281 | Cardiovascular biomarkers: increasing impact of laboratory medicine in cardiology practice |
| Q37859518 | Serological Evidence of Chronic Chlamydia pneumoniae Infection in Coronary Artery Disease |
| Q35206514 | The increasing impact of laboratory medicine on clinical cardiology |
Search more.